Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ronald J Messer
Affiliation
National Institute of Allergy and Infectious Diseases, National Institutes of Health
ORCID
Career Start Year
1972
Papers
54
H Index
30
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36434839
Practical Mouse Model to Investigate Therapeutics for Staphylococcusaureus Contaminated Surgical Mesh Implants.
J Surg Res
2023
36073812
CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir.
mBio
2022
34311582
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
mBio
2021
33821272
Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.
bioRxiv
2021
32576678
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
mBio
2020
30670616
Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.
mBio
2019
31792317
Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir.
Sci Rep
2019
30770827
A functional subset of CD8[+] T cells during chronic exhaustion is defined by SIRPα expression.
Nat Commun
2019
29112072
An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
AIDS
2018
29614127
Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.
PLoS One
2018
28765225
B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.
mBio
2017
28330900
Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and Testes.
J Immunol
2017
27099312
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
J Virol
2016
26609939
No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts.
Virology
2016
26670699
Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
PLoS One
2015
26463758
Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation.
Sci Rep
2015
24889233
Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes.
Virology
2014
25098294
Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.
J Immunol
2014
24769067
Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(-/-)γc(-/-)CD47(-/-) background.
J Immunol Methods
2014
24872193
Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.
J Immunol
2014
23645880
IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection.
J Immunol
2013
24021673
BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.
Blood
2013
22821964
Negative impact of IFN-γ on early host immune responses to retroviral infection.
J Immunol
2012
21047954
Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell response.
J Virol
2011
21543647
Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways.
J Immunol
2011
19568424
Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells.
PLoS One
2009
19587016
Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads.
J Immunol
2009
19812147
Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection.
J Virol
2009
17959678
Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.
J Virol
2008
18772436
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Science
2008
18390707
CD137 costimulation of CD8+ T cells confers resistance to suppression by virus-induced regulatory T cells.
J Immunol
2008
16517701
In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells.
J Immunol
2006
16051854
CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.
J Virol
2005
15030773
Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.
Immunity
2004
15297622
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Proc Natl Acad Sci U S A
2004
15479805
Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection.
J Virol
2004
11739713
Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression.
J Virol
2002
12133998
Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.
J Virol
2002
11836400
Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.
J Virol
2002
11119573
CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.
J Virol
2001
11459933
Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.
Proc Natl Acad Sci U S A
2001
11134279
Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.
J Virol
2001
10603387
Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.
Infect Immun
2000
10479155
The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.
J Infect Dis
1999
10092812
Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
J Immunol
1999
9730883
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
J Exp Med
1998
7476173
Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin.
Mol Microbiol
1995
8530486
Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli heat-labile enterotoxin. Evidence for a catalytic role for glutamic acid 112.
J Biol Chem
1995
7927684
Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.
Infect Immun
1994
1729180
Evidence for proteolytic cleavage of the 120-kilodalton outer membrane protein of rickettsiae: identification of an avirulent mutant deficient in processing.
Infect Immun
1992
1 - 50 of 54
Column Actions
Search
Recommended Authors
Blake Frey
University of Alabama at Birmingham
Career Start Year
2014
Number of shared co-authors
0
Peiwen Lu
Yale University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
Jocelyn T Kim
University of California Los Angeles
Career Start Year
2011
Number of shared co-authors
0
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year
2004
Number of shared co-authors
0
Cherie T Ng
The Scripps Research Institute
Career Start Year
2004
Number of shared co-authors
1
Andrea Paun
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Kara L Cummings
University of Virginia School of Medicine
Career Start Year
2003
Number of shared co-authors
0
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year
2003
Number of shared co-authors
0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year
2001
Number of shared co-authors
0
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year
2000
Number of shared co-authors
0
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
0
P Robert Beatty
School of Public Health, University of California berkeley
Career Start Year
1990
Number of shared co-authors
2
Akiko Iwasaki
Yale University
Career Start Year
1990
Number of shared co-authors
0
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1990
Number of shared co-authors
10
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year
1990
Number of shared co-authors
0
Drake Laface
Merck & Co. Inc.
Career Start Year
1987
Number of shared co-authors
0
David B Weiner
Wistar Institute
Career Start Year
1986
Number of shared co-authors
3
Jody L Baron
University of California San Francisco
Career Start Year
1984
Number of shared co-authors
1
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
4
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year
1981
Number of shared co-authors
2
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year
1980
Number of shared co-authors
10
Judy Lieberman
Boston Children's Hospital
Career Start Year
1978
Number of shared co-authors
1
Carl F Ware
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1977
Number of shared co-authors
1
Merril Gersten
University of California
Career Start Year
1976
Number of shared co-authors
0
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year
1976
Number of shared co-authors
1
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year
1975
Number of shared co-authors
0
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
1
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year
1973
Number of shared co-authors
0
Ulrich H Koszinowski
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Career Start Year
1973
Number of shared co-authors
0
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1966
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Kim J Hasenkrug
National Institute of Allergy and Infectious Diseases
Co-authored papers
41
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Co-authored papers
17
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Co-authored papers
5
Mario L Santiago
Co-authored papers
5
Deepashri Rao
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
3
Erik Van Dis
University of California berkeley
Co-authored papers
3
Marek Widera
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Co-authored papers
3
Mark M Davis
Co-authored papers
2
Kimberly Meade-White
National Institutes of Allergy and Infectious Disease, National Institutes of Health
Co-authored papers
2
Shimon Sakaguchi
Institute for Frontier Medical Sciences, Kyoto University
Co-authored papers
2
Warner C Greene
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers
2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Aaron M Newman
Stanford University
Co-authored papers
1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Co-authored papers
1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Co-authored papers
1
Mauricio Montano
Gladstone Institutes
Co-authored papers
1
Zachary W Grimmett
J. David Gladstone Institutesgrid.249878.8
Co-authored papers
1
Elizabeth R Fischer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
1
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Johanne H Egedal
J. David Gladstone Institutesgrid.249878.8
Co-authored papers
1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Paul D Bieniasz
The Rockefeller University
Co-authored papers
1
Thomas A Packard
J. David Gladstone Institutesgrid.249878.8
Co-authored papers
1
Eytan Herzig
J. David Gladstone Institutesgrid.249878.8
Co-authored papers
1
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
1
Roland Schwarzer
University Hospital Essen, Institute for Translational HIV Research
Co-authored papers
1
Steven G Deeks
University of California san francisco
Co-authored papers
1
Feng Hsiao
University of California San Francisco
Co-authored papers
1
Xiaoyu Luo
Gladstone Institutes, University of California san francisco
Co-authored papers
1
Todd M Allen
Co-authored papers
1
1 - 30